Tag: toxicology drug screening market report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Toxicology Drug Screening Market Growth From $23.49 Billion In 2026 To $33.47 Billion By 2030 At A CAGR Of 9.2%

The toxicology drug screening market size has seen robust growth in recent years. It is forecast to expand from $21.44 billion in 2025 to $23.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The expansion observed historically can be attributed to the reliance on manual toxicology testing methods, limited laboratory automation, the increasing prevalence of substance abuse monitoring, tightening regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market is anticipated to show significant expansion in the upcoming years. Its value is projected to reach $33.48 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.2%. This expected increase during the forecast period can be attributed to the advancement of AI-driven predictive toxicology tools, the integration of genomics and transcriptomics into screening, the rise of contract research organizations (CROs), an escalating demand for real-time drug monitoring systems, and the implementation of cloud-based and secure data management platforms. Notable trends for this period include the increasing adoption of high-throughput screening technologies, the integration of LIMS and laboratory information systems, the growing utilization of predictive and AI-powered toxicology platforms, the expansion of workplace drug screening programs, and a strengthened focus on data security and compliance standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=79588078&type=smp&name=Toxicology%20Drug%20Screening%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Toxicology Drug Screening Market Development Factors: What’s Supporting Demand?

The escalating incidence of drug abuse is anticipated to drive the growth of the toxicology drug screening market moving forward. Drug abuse refers to the damaging or excessive consumption of drugs for non-medical intentions, which negatively impacts a person’s health and daily life. The rise in drug abuse prevalence is attributed to increased stress and mental health struggles, leading many individuals to improperly use substances as a coping strategy. Toxicology drug screening is valuable in the context of drug abuse because it aids in identifying the presence of drugs or their metabolites within an individual’s body, thus enabling timely recognition, diagnosis, and management of substance misuse or overdose situations. For instance, in August 2024, information from the National Records of Scotland (NRS), a Scotland-based government department, showed that Scotland recorded 1,172 drug misuse deaths in 2023, representing a 12% rise (121 additional deaths) compared to 2022. Hence, the increasing prevalence of drug abuse is a primary stimulant for the toxicology drug screening market.

Toxicology Drug Screening Market Segment Breakdown: Which Categories Lead On Revenue?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Toxicology Drug Screening Market Transformation Trends: What Innovations Are Driving Change?

Major companies within the toxicology drug screening market are focusing on implementing innovative solutions, such as the 3D liver microphysiological system, which facilitates the culturing of highly biomimetic human liver microtissues featuring organized cellular structures and active metabolic function. The 3D liver microphysiological system (MPS) serves as an advanced in vitro platform, specifically engineered to more accurately replicate the human liver’s physiological microenvironment than traditional cell culture methods, and typically involves growing multiple types of human liver cells. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit is developed for the in vitro profiling of human drug-induced liver injury and includes a highly characterized 3D liver microphysiological system (MPS) that successfully recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it offers simple integration of organ-on-a-chip technology with a plug-and-play format, thereby simplifying deployment and reducing time to adoption.

Toxicology Drug Screening Market Leading Players And Competitive Positioning

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

View The Full Toxicology Drug Screening Market Report:

https://thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Toxicology Drug Screening Market Top Region By Revenue And Market Share

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Toxicology Drug Screening Market Size, Value And Growth Trends Through 2030

The toxicology drug screening market has experienced significant expansion over the past several years, with its valuation climbing from $21.44 billion in 2025 to an anticipated $23.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.6%. This upward trajectory during the historical period was largely driven by factors such as a dependence on manual toxicology testing techniques, minimal levels of laboratory automation, a rising frequency of substance abuse monitoring programs, heightened regulatory scrutiny, and the integration of traditional bioanalytical instruments.

The toxicology drug screening market is projected to experience robust expansion over the coming years, reaching a valuation of $33.48 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by factors such as the emergence of AI-powered predictive toxicology tools, the incorporation of genomics and transcriptomics into screening processes, the proliferation of contract research organizations (CROs), an increasing need for real-time drug monitoring systems, and the deployment of cloud-based and secure data management platforms. Key trends influencing this period encompass a rising reliance on high-throughput screening technologies, the integration of laboratory information management systems (LIMS), the growing utilization of predictive and AI-enhanced toxicology platforms, the broadening of workplace drug screening initiatives, and a heightened emphasis on data security and regulatory compliance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Toxicology Drug Screening Market Growth Drivers And Industry Catalysts

The growing incidence of substance abuse is anticipated to drive the expansion of the toxicology drug screening market in the coming years. Drug abuse refers to the harmful or excessive consumption of drugs for non-therapeutic purposes, which adversely affects an individual’s health and overall well-being. This trend is escalating due to heightened stress levels and mental health issues, prompting many people to turn to substance misuse as a coping mechanism. Toxicology drug screening plays a crucial role in addressing drug abuse by identifying the presence of drugs or their metabolites in the body, facilitating early detection, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government agency based in Scotland, reported 1,172 drug misuse deaths in 2023, representing a 12% increase (121 more deaths) compared to 2022. Consequently, the rising prevalence of drug abuse is fueling growth in the toxicology drug screening market.

Toxicology Drug Screening Market Segment Analysis: What Are The Major Market Categories?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Toxicology Drug Screening Market Trends Influencing Long-Term Demand

Key players in the toxicology drug screening industry are concentrating on launching innovative products, such as the 3D liver microphysiological system, a technology that enables the cultivation of highly biomimetic human liver microtissues characterized by organized cellular structures and robust metabolic activity. This 3D liver microphysiological system (MPS) represents a sophisticated in vitro platform, engineered to more faithfully mimic the human liver’s physiological surroundings compared to conventional cell culture methods, typically involving the culture of diverse human liver cell types. A concrete example occurred in February 2025 when CN Bio Innovations Ltd., a UK-based life sciences firm specializing in organ-on-a-chip (OOC) technologies, introduced the PhysioMimix DILI assay kit. This integrated laboratory kit was designed for in vitro evaluation of human drug-induced liver injury, incorporating a well-characterized 3D liver MPS that reconstructs metabolically active, highly functional human liver tissue along with Kupffer cells. Moreover, it facilitates seamless integration of organ-on-a-chip technology through a plug-and-play format, streamlining implementation and shortening the time required for widespread adoption.

Toxicology Drug Screening Market Leading Companies Driving Competitive Growth

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Access The Complete Toxicology Drug Screening Market Report:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Toxicology Drug Screening Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Toxicology Drug Screening Market Change Between 2026 And 2030?

The toxicology drug screening market size has shown substantial growth over recent years. This market is projected to expand from $21.44 billion in 2025 to $23.5 billion in 2026, indicating a compound annual growth rate (CAGR) of 9.6%. During the historic period, this growth was driven by factors such as a reliance on manual toxicology testing methods, limited laboratory automation, the increasing prevalence of substance abuse monitoring, rising regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market is anticipated to experience substantial expansion over the coming years. It is projected to reach $33.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be primarily attributed to the emergence of AI-driven predictive toxicology solutions, the incorporation of genomics and transcriptomics into screening processes, the expansion of contract research organizations (CROs), an increasing need for real-time drug monitoring systems, and the adoption of cloud-based, secure data management platforms. Key trends anticipated within this period encompass the increasing embrace of high-throughput screening technologies, the integration of LIMS and other laboratory information systems, the escalating utilization of predictive and AI-powered toxicology platforms, the broadening scope of workplace drug screening initiatives, and a heightened emphasis on data security and compliance standards.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Key Growth Drivers Are Influencing The Toxicology Drug Screening Market?

An increase in drug abuse cases is projected to boost the expansion of the toxicology drug screening market. Drug abuse involves the detrimental or overuse of substances for non-medical reasons, adversely affecting an individual’s health and quality of life. The escalating incidence of drug abuse stems from heightened stress and mental health issues, prompting numerous people to turn to substance misuse as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and ongoing oversight of substance misuse or potential overdose. As an illustration, in August 2024, data from the National Records of Scotland (NRS), a government body in Scotland, revealed that Scotland documented 1,172 drug misuse deaths in 2023, representing a 12% increase (121 additional deaths) compared to the figures from 2022. Consequently, the increasing occurrence of drug abuse acts as a key stimulant for the toxicology drug screening market.

What Segment Types Are Included In The Toxicology Drug Screening Market Analysis?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Trends Are Shaping The Toxicology Drug Screening Market Landscape?

Leading companies in the toxicology drug screening market are concentrating on introducing innovative solutions, such as the 3D liver microphysiological system, which facilitates the culturing of highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. The 3D liver microphysiological system (MPS) stands as an advanced in vitro platform, meticulously designed to replicate the physiological microenvironment of the human liver more accurately than traditional cell culture methods, typically involving the cultivation of multiple types of human liver cells. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit is developed for the in vitro profiling of human drug-induced liver injury and features a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.

Which Companies Are Influencing The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Access The Complete Toxicology Drug Screening Market Report:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Region Is The Dominant Market In The Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Toxicology Drug Screening Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Toxicology Drug Screening Market Compare Between 2026 And 2030?

The toxicology drug screening market has seen substantial growth in recent years. This market is anticipated to expand from $21.44 billion in 2025 to $23.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The historical growth of this market can be attributed to factors such as dependence on manual toxicology testing methods, limited automation in laboratories, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $33.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is fueled by factors such as the creation of AI-driven predictive toxicology tools, the incorporation of genomics and transcriptomics into screening methods, the expansion of contract research organizations (cros), an increasing need for real-time drug monitoring systems, and the deployment of cloud-based, secure data management platforms. Significant trends for the forecast period encompass the increasing embrace of high-throughput screening technologies, the integration of lims and laboratory information systems, a heightened reliance on predictive and AI-powered toxicology platforms, the broadening of workplace drug screening programs, and an intensified focus on data security and compliance standards.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Leading Drivers Are Supporting The Toxicology Drug Screening Market Expansion?

The toxicology drug screening market is anticipated to expand due to the increasing incidence of drug abuse. Drug abuse refers to the detrimental or excessive consumption of drugs for reasons other than medical, adversely affecting an individual’s health and life. The growing occurrence of drug abuse stems from heightened stress and mental health issues, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or potential overdose. For example, data released in August 2024 by the National Records of Scotland (NRS), a government department in Scotland, revealed that Scotland documented 1,172 drug misuse deaths in 2023, representing a 12% increase (121 additional deaths) from the figures in 2022. Consequently, the increasing prevalence of drug abuse serves as a key driver for the toxicology drug screening market.

Which Segments Define The Toxicology Drug Screening Market Segment Structure?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Trends Are Impacting The Progress Of The Toxicology Drug Screening Market?

Leading enterprises within the toxicology drug screening market are prioritizing the introduction of groundbreaking solutions, such as the 3D liver microphysiological system, which facilitates the cultivation of highly biomimetic human liver microtissues exhibiting organized cellular structures and dynamic metabolic activity. This 3D liver microphysiological system (MPS) functions as an advanced in vitro platform, specifically engineered to mimic the physiological surroundings of the human liver with greater precision compared to conventional cell culture techniques, often involving the growth of various human liver cell types. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences firm specializing in organ-on-a-chip (OOC) technologies, unveiled the PhysioMimix DILI assay kit. This comprehensive laboratory kit is designed for the in vitro assessment of human drug-induced liver injury and incorporates a thoroughly characterized 3D liver microphysiological system (MPS) capable of recreating metabolically active, highly functional human liver tissue along with Kupffer cells. Furthermore, it allows for easy integration of organ-on-a-chip technology through a plug-and-play format, thereby streamlining its deployment and accelerating the adoption process.

Who Are The Established Players Within The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Get The Full Toxicology Drug Screening Market Report:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Region Dominates The Toxicology Drug Screening Market By Market Share?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Toxicology Drug Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Toxicology Drug Screening Market By 2030 Starting From Its 2026 Size?

The toxicology drug screening market size has shown robust growth over recent years. It is forecast to expand from $21.44 billion in 2025 to $23.5 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.6%. The market’s historical growth can be attributed to factors such as dependence on manual toxicology testing methods, restricted laboratory automation, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the incorporation of conventional bioanalytical instrumentation.

The toxicology drug screening market is poised for substantial expansion in the coming years. It will grow to $33.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by several factors, including the advancement of AI-powered predictive toxicology instruments, the incorporation of genomics and transcriptomics into screening processes, the expansion of contract research organizations (CROs), an increasing need for real-time drug monitoring solutions, and the adoption of cloud-based and secure data management infrastructures.

Key trends anticipated during this forecast period encompass the increasing widespread use of high-throughput screening methods, the merging of LIMS and laboratory information systems, the expanding application of predictive and AI-driven toxicology platforms, the broadening scope of workplace drug screening initiatives, and a heightened emphasis on data security and regulatory adherence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Drivers Are Shaping The Future Growth Of The Toxicology Drug Screening Market?

The anticipated expansion of the toxicology drug screening market is linked to the growing occurrence of drug abuse. This refers to the detrimental or excessive consumption of substances for reasons other than medical, which adversely affects an individual’s well-being and existence. The increase in drug abuse cases is attributed to heightened stress and mental health issues, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within the human body, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or overdose situations. An illustrative example comes from August 2024, when the National Records of Scotland (NRS), a government department in Scotland, reported that Scotland experienced 1,172 drug misuse deaths in 2023, representing a 12% surge, or 121 more fatalities, than in 2022. Consequently, the expanding scope of drug abuse is a primary impetus for the toxicology drug screening market.

Which Segment Categories Define The Toxicology Drug Screening Market?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

What Major Market Trends Are Driving Changes In The Toxicology Drug Screening Market?

Leading companies in the toxicology drug screening market are prioritizing the introduction of innovative solutions, such as the 3D liver microphysiological system, which facilitates the culturing of highly biomimetic human liver microtissues with organized cellular structures and active metabolic function. The 3D liver microphysiological system (MPS) serves as an advanced in vitro platform, engineered to more accurately replicate the physiological microenvironment of the human liver than traditional cell culture methods, typically involving the cultivation of multiple human liver cell types. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit is designed for in vitro profiling of human drug-induced liver injury and includes a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.

Who Are The Top Companies Competing In The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Read the full toxicology drug screening market report here:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Geographic Regions Are Influencing Demand In The Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Toxicology Drug Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the toxicology drug screening market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Toxicology Drug Screening Market from 2026 to 2030?

The toxicology drug screening market has shown substantial growth in recent years. It is anticipated to expand from $21.44 billion in 2025 to $23.5 billion by 2026, achieving a compound annual growth rate (CAGR) of 9.6%. This historical expansion can be attributed to factors like the reliance on manual toxicology testing methods, limited laboratory automation, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market size is anticipated to expand significantly in the coming years, with projections indicating it will reach $33.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is primarily driven by the development of AI-driven predictive toxicology tools, the integration of genomics and transcriptomics in screening, the expansion of contract research organizations (CROS), a rising demand for real-time drug monitoring systems, and the implementation of cloud-based, secure data management platforms. Furthermore, major trends throughout this period include the increasing adoption of high-throughput screening technologies, the integration of LIMS and laboratory information systems, the growing utilization of predictive and AI-powered toxicology platforms, the broadening scope of workplace drug screening programs, and an elevated emphasis on data security and compliance standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Drivers Are Affecting Demand In The Toxicology Drug Screening Market?

The escalating occurrence of drug abuse is anticipated to fuel the expansion of the toxicology drug screening market in the future. This refers to the detrimental or excessive consumption of drugs for reasons other than medical, adversely affecting an individual’s well-being and existence. The frequency of drug abuse is increasing, driven by heightened stress and difficulties with mental health, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or potential overdose. For example, data from August 2024, provided by the National Records of Scotland (NRS), a Scotland-based government department, revealed that Scotland documented 1,172 drug misuse deaths in 2023. This represented a 12% increase, or 121 additional deaths, when compared to the figures from 2022. Consequently, the growing incidence of drug abuse is propelling the toxicology drug screening market.

Which Segment Groups Are Influencing The Toxicology Drug Screening Market?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Trends Are Influencing The Development Of The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are focusing on introducing innovative solutions, such as the 3D liver microphysiological system, which enables the culturing of highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. The 3D liver microphysiological system (MPS) represents an advanced in vitro platform engineered to replicate the physiological microenvironment of the human liver with greater precision than traditional cell culture methods, typically involving the cultivation of multiple types of human liver cells. For instance, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit was developed for in vitro profiling of human drug-induced liver injury and incorporates a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it facilitates effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.

Who Are The Prominent Global Companies Shaping The Toxicology Drug Screening Market Landscape?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Toxicology Drug Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Toxicology Drug Screening Market?_x000D_

The toxicology drug screening market size has experienced significant expansion in recent years. This market is anticipated to increase from $19.56 billion in 2024 to $21.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. The historical growth of the market can be linked to a rise in drug abuse cases, the enforcement of workplace drug testing regulations, the growing application of toxicology screening in sports, the expansion of forensic toxicology services, and an increase in criminal investigations that demand toxicology reports._x000D_

_x000D_

The toxicology drug screening market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $30.67 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth is driven by factors such as the increasing need for personalized medicine, stricter regulatory oversight of drug safety, the growing prevalence of cannabis and synthetic drug use, the development of healthcare infrastructure in nascent markets, and the increasing occurrence of substance abuse. Key trends expected during this period involve enhancements in high-throughput screening technologies, sophisticated integration of artificial intelligence into toxicology analysis, the creation of point-of-care toxicology examinations, advancements in biomarker-based screening techniques, and progress in automation and robotics for drug screening._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp_x000D_

_x000D_

#What Are The Top Growth Drivers Impacting The Toxicology Drug Screening Market Outlook?#_x000D_

The increasing occurrence of drug abuse is anticipated to fuel the expansion of the toxicology drug screening market. Drug abuse is defined as the detrimental or excessive consumption of substances for non-medical reasons, adversely affecting an individual’s well-being and existence. The escalating prevalence of drug abuse is attributed to heightened stress and mental health challenges, prompting many individuals to misuse substances as a coping strategy. Toxicology drug screening proves instrumental in combating drug abuse by detecting the presence of drugs or their metabolites in the human body, thereby facilitating prompt detection, assessment, and oversight of substance misuse or overdose situations. Illustrating this trend, data released in August 2024 by the National Records of Scotland (NRS), a Scotland-based government department, indicated that Scotland recorded 1,172 drug misuse deaths in 2023, a 12% rise (121 additional deaths) when compared to 2022. Consequently, the escalating frequency of drug abuse serves as a primary impetus for the growth of the toxicology drug screening market._x000D_

_x000D_

#What Are The Major Segment Types Covered In The Toxicology Drug Screening Market?#_x000D_

The toxicology drug screening market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Monitoring And Logging, Security, Storage And Continuous Integration Or Continuous Deployment, Management And Orchestration, Networking And Data Management Services, Other Types_x000D_

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity_x000D_

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening_x000D_

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications_x000D_

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities_x000D_

_x000D_

Subsegments:_x000D_

1) By Monitoring And Logging: Real-Time Drug Monitoring Systems, Bioanalytical Instrumentation Logs, Toxicity Alert Notification Systems, Compliance And Audit Trail Monitoring_x000D_

2) By Security: Data Encryption Solutions For Lab Reports, Access Control Systems For Toxicology Data, Secure Sample Tracking Systems, HIPAA Or GDPR-Compliant Drug Testing Platforms_x000D_

3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions, Automated Toxicology Report Generation Pipelines, LIMS (Laboratory Information Management Systems) Integration Tools, Version Control For Test Protocols And Databases_x000D_

4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs, Centralized Dashboard For Drug Screening Management, Multi-Site Test Scheduling And Coordination Platforms, Vendor Management Systems For Lab Supplies_x000D_

5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange, Toxicology Data Integration Services With EHR/EMR Systems, Remote Access For Toxicology Results And Analysis, Data Warehousing For Toxicology And Screening Records_x000D_

6) By Other Types: AI-Powered Predictive Toxicology Platforms, Mobile Drug Screening Applications, Blockchain-Based Chain Of Custody Solutions, Voice And Image Recognition Tools In Toxicology_x000D_

_x000D_

#Which Ongoing Trends Are Expected To Shape The Toxicology Drug Screening Market Outlook?#_x000D_

Leading firms in the toxicology drug screening market are prioritizing the development of novel solutions, like forensic toxicology screening, to improve the precision and swiftness of identifying substances across clinical, forensic, and occupational environments. Forensic toxicology screening involves examining biological specimens to pinpoint and recognize drugs, poisons, or toxins implicated in criminal acts, mishaps, or fatalities, serving legal investigative requirements. As an illustration, during June 2022, Thermo Fisher Scientific Inc., a biotechnology and life sciences firm based in the US, introduced the ToxSpec Analyzer, an all-encompassing LC-MS (liquid chromatography-mass spectrometry) solution specifically designed for clinical and forensic toxicology screening. This system combines hardware components, software applications, and proven methodologies to automate and simplify the process of screening drug analytes, rendering it approachable even for laboratories unfamiliar with LC-MS/MS technology. The ToxSpec Analyzer improves workflow effectiveness, boosts confidence in identification, and provides adaptability to incorporate additional compounds as required._x000D_

_x000D_

#Which Global Market Leaders Are Shaping The Future Of The Toxicology Drug Screening Sector?#_x000D_

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc. _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report_x000D_

_x000D_

#What Are The Key Regional Factors Influencing The Toxicology Drug Screening Market Growth?#_x000D_

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized Version Of The Toxicology Drug Screening Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2025, By The Business Research Company#_x000D_

_x000D_

In Vitro Toxicology Testing Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report_x000D_

_x000D_

Adme Toxicology Testing Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report_x000D_

_x000D_

Artificial Intelligence Ai In Predictive Toxicology Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Toxicology Drug Screening Market Evolve in Terms of Growth and Size by 2029?

The market size for toxicology drug screening has experienced robust growth in the recent past. The market is predicted to expand from a value of $19.56 billion in 2024 to reach $21.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the expansion in the historic period include an escalation in drug misuse incidents, execution of drug testing rules at workplaces, the growing preference for toxicology screening in sports, the broadening scope of forensic toxicology services, and an increase in criminal inquiries necessitating toxicology reports.

The market size of toxicology drug screening is predicted to experience significant growth in the upcoming years, escalating to $30.67 billion in 2029, with a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period can be attributed to factors such as the rising demand for personalized medicine, increased focus on drug safety regulations, heightened usage of cannabis and synthetic drugs, expansion of healthcare infrastructure in developing markets, and an upsurge in substance abuse cases. Noteworthy trends for the forecast period include progress in high-throughput screening technologies, the advanced incorporation of AI in toxicology examinations, creation of point-of-care toxicology tests, breakthroughs in biomarker-based screening techniques, and advancements in automation and robotics in drug screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What factors are expected to fuel Toxicology Drug Screening market growth in the coming years?

The increased instances of drug misuse are projected to fuel the expansion of the toxicology drug screening market in the future. Drug misuse is the harmful or surplus use of substances for non-therapeutic reasons, adversely influencing an individual’s wellbeing and life. The spread of drug misuse is amplifying due to increased levels of stress and mental health problems, coaxing many people to exploit substances as a method of coping. Toxicology drug screening is helpful in instances of drug misuse as it aids in detecting the existence of drugs or their by-products in an individual’s body, facilitating early recognition, diagnosis, and tracking of substance misuse or overdose. For example, as per the National Records of Scotland (NRS), a government department based in Scotland, it was recorded that there were 1,172 drug misuse-related deaths in 2023, representing a 12% increase or 121 additional deaths compared to 2022. Consequently, the escalating instances of drug misuse are stimulating the growth of the toxicology drug screening market.

What Are The Key Findings From The Segmentation Analysis Of The Toxicology Drug Screening Market?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Monitoring And Logging, Security, Storage And Continuous Integration Or Continuous Deployment, Management And Orchestration, Networking And Data Management Services, Other Types

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Monitoring And Logging: Real-Time Drug Monitoring Systems, Bioanalytical Instrumentation Logs, Toxicity Alert Notification Systems, Compliance And Audit Trail Monitoring

2) By Security: Data Encryption Solutions For Lab Reports, Access Control Systems For Toxicology Data, Secure Sample Tracking Systems, HIPAA Or GDPR-Compliant Drug Testing Platforms

3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions, Automated Toxicology Report Generation Pipelines, LIMS (Laboratory Information Management Systems) Integration Tools, Version Control For Test Protocols And Databases

4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs, Centralized Dashboard For Drug Screening Management, Multi-Site Test Scheduling And Coordination Platforms, Vendor Management Systems For Lab Supplies

5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange, Toxicology Data Integration Services With EHR/EMR Systems, Remote Access For Toxicology Results And Analysis, Data Warehousing For Toxicology And Screening Records

6) By Other Types: AI-Powered Predictive Toxicology Platforms, Mobile Drug Screening Applications, Blockchain-Based Chain Of Custody Solutions, Voice And Image Recognition Tools In Toxicology

Which Trends Are Expected To Shape The Future Of The Toxicology Drug Screening Market?

Leading firms in the toxicology drug screening market are concentrating on the development and launch of innovative solutions, including forensic toxicology screening. This approach aims to improve the precision and speed of substance detection in clinical, forensic, and occupational environments. Forensic toxicology screening involves the examination of biological samples to uncover and identify drugs, toxins, or poisons connected with crimes, accidents, or fatalities for legal inquiries. In June 2022, for example, Thermo Fisher Scientific Inc., a biotechnology and life sciences enterprise based in the United States, introduced the ToxSpec Analyzer. This comprehensive LC-MS (liquid chromatography-mass spectrometry) solution is specifically designed for clinical and forensic toxicology screening. It comprises hardware, software and proven methodologies that automate and streamline the drug analyte screening process, ensuring it is manageable even for labs unfamiliar with LC-MS/MS technology. The ToxSpec Analyzer enhances operational efficiency, heightens the confidence in identification, and provides the capacity to incorporate new compounds as required.

What Are The Most Active Companies In The Toxicology Drug Screening Market Today?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Regional Markets Are Attracting The Most Investment In Toxicology Drug Screening?

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Toxicology Drug Screening Market Size Changed, over the years?

In the past few years, the size of the toxicology drug screening market has experienced significant growth. It is projected to increase from $19.56 billion in 2024 to $21.44 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the historic period include a surge in drug abuse cases, the enforcement of workplace drug testing policies, the widespread use of toxicology screening in sports, the development of forensic toxicology services, and the escalating demand for toxicology reports in criminal investigations.

How Much Will the Toxicology Drug Screening Market Be Worth in 2029?

The market size of toxicology drug screening is set to experience substantial growth in the upcoming years, rising to $30.67 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. This expected growth during the forecasted period can be ascribed to the escalating demand for personalized medicine, augmented regulatory concentration on drug safety, increasing consumption of cannabis and synthetic drugs, expansion of health infrastructure in emerging markets, and growing cases of substance abuse. The forecasted period will also see major trends such as improvements in high-throughput screening technologies, enhanced use of AI in toxicology examination, growth of point-of-care toxicology tests, novel ideas in biomarker-based screening techniques, and progress in automation and robotics for drug screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

Which is the Largest Company in the Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

What Are the Main Market Drivers in the Toxicology Drug Screening Industry?

The toxicology drug screening market is projected to expand due to the escalating epidemic of drug misuse. Drug misuse, a destructive or excessive consumption of drugs for non-therapeutic reasons, negatively affects an individual’s health and overall life. The drug misuse trend escalates as individuals grapple with increasing stress and mental health issues, causing many to turn to substance misuse as a coping strategy. Toxicology drug screening plays a critical role in this context by identifying the presence of drugs or their by-products in an individual’s body, facilitating premature detection, diagnosis, and supervision of substance misuse or overdose. To illustrate, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, a 12% increase (121 extra deaths) compared to 2022. As a result, the escalating drug misuse epidemic is propelling the growth of the toxicology drug screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

How Is the Toxicology Drug Screening Market Segments Structured?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Monitoring And Logging, Security, Storage And Continuous Integration Or Continuous Deployment, Management And Orchestration, Networking And Data Management Services, Other Types

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Monitoring And Logging: Real-Time Drug Monitoring Systems, Bioanalytical Instrumentation Logs, Toxicity Alert Notification Systems, Compliance And Audit Trail Monitoring

2) By Security: Data Encryption Solutions For Lab Reports, Access Control Systems For Toxicology Data, Secure Sample Tracking Systems, HIPAA Or GDPR-Compliant Drug Testing Platforms

3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions, Automated Toxicology Report Generation Pipelines, LIMS (Laboratory Information Management Systems) Integration Tools, Version Control For Test Protocols And Databases

4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs, Centralized Dashboard For Drug Screening Management, Multi-Site Test Scheduling And Coordination Platforms, Vendor Management Systems For Lab Supplies

5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange, Toxicology Data Integration Services With EHR/EMR Systems, Remote Access For Toxicology Results And Analysis, Data Warehousing For Toxicology And Screening Records

6) By Other Types: AI-Powered Predictive Toxicology Platforms, Mobile Drug Screening Applications, Blockchain-Based Chain Of Custody Solutions, Voice And Image Recognition Tools In Toxicology

What Strategic Trends Are Transforming the Toxicology Drug Screening Market?

Leading corporations in the toxicology drug screening market are increasingly directing their efforts towards the introduction of cutting-edge solutions such as forensic toxicology screening. This innovation aims to improve the speed and precision of substance detection in clinical, forensic, and occupational environments. Forensic toxicology screening entails the examination of biological specimens to detect and identify drugs, toxins, or poisons involved in criminal activities, accidents, or fatalities, primarily for legal investigative reasons. For example, Thermo Fisher Scientific Inc., a biotechnology and life sciences firm based in the US, unveiled the ToxSpec Analyzer in June 2022. This comprehensive LC-MS (liquid chromatography-mass spectrometry) solution is specifically designed for clinical and forensic toxicology screening applications. The system unifies hardware, software, and validated methodologies to automate and simplify the drug analytes screening process, making it user-friendly even for labs unfamiliar with LC-MS/MS technology. Through this innovation, the ToxSpec Analyzer enhances workflow productivity, heightens identification certainty, and provides the option to incorporate new compounds as necessary.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Global Regions Offer the Highest Growth in the Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24728

This Report Delivers Insight On:

1. How big is the toxicology drug screening market, and how is it changing globally?

2. Who are the major companies in the toxicology drug screening market, and how are they performing?

3. What are the key opportunities and risks in the toxicology drug screening market right now?

4. Which products or customer segments are growing the most in the toxicology drug screening market?

5. What factors are helping or slowing down the growth of the toxicology drug screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model